The Therapeutic Goods Administration (TGA) has provisionally approved two oral antiviral treatments for COVID-19. Here’s what pharmacists need to know.

The TGA has told pharmacists, prescribers and patients to expect a shortage of Estradot (estradiol) HRT transdermal products until July 2021.

In line with TGA regulatory changes to enhance medicine safety, PSA has developed a cautionary advisory label that warns consumers about the risk of opioid overdose and dependence.

The Therapeutic Goods Administration (TGA) has reviewed their proposal to upschedule all alkyl nitrites to Schedule 9 (S9), but pharmacists will need to ensure...

Data from the National Notifiable Diseases Surveillance System reveals cases of cryptosporidiosis have skyrocketed in 2024.

The changes to ongoing Continued Dispensing arrangements after the expiry of the emergency measure came as a shock to many pharmacists.